24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Kadimastem
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
21:53
Iron Beam and Iron Dome at the frontlines of a quiet Israel-UAE alliance
20:14
Air Doctor: “Perks or bonuses don’t solve burnout where employees are balancing ongoing security concerns”
16:51
Full list of Israeli startup M&As in 2026
16:46
Cisco acquires AI security startup Astrix for $400 million
More stories
Buzz
Most popular
Daily
Weekly
1
Cisco acquires AI security startup Astrix for $400 million
2
Five bidders advance in Nice’s $2.5 billion Actimize sale process
3
The 50 most promising Israeli startups - 2026
4
Israeli startup bets on psychedelic mushrooms for mental health treatment
5
Israeli tech veterans launch $100 million AI and cyber fund
More news
Kadimastem
2 stories about Kadimastem
Israeli and French Biotech Companies Partner to Fight Diabetes With Bio-Artificial Pancreas
12.11.18
|
Lilach Baumer
Israel-based Kadimastem and France-headquartered Defymed will receive a grant of around $1.5 million from the European Commission's Eurostars program to develop the technology to treat type 1 diabetes
Kadimastem Gets FDA Orphan Drug Designation for ALS Drug
04.11.18
|
Lilach Baumer
The biotech company is currently conducting an early clinical trial in Israel and expects results in mid-2019